Venrock partner Nimish Shah speaks with Jason Fenton, managing director and head of health care capital markets at Cowen, to discuss the explosion of activity in the biotech IPO market this year. Fenton dives into the pros and cons of a virtual IPO process and shares best practices for companies looking to go public. Shah and Fenton outline some of the important factors to consider when choosing a bank and touch on common mistakes CEOs make while going through an IPO. Fenton also walks through the components of a recent successful IPO deal and provides his expectations for the biotech market in 2021. 

  • Subscribe:


Want more? Here’s the latest on Running Through Walls.

Farzad Mostashari, founder and CEO of Aledade, speaks with Venrock’s Bryan Roberts and Bob Kocher about improving the quality and efficiency of patient care with a focus on preventative care. With the recent launch of Aledade Care Solutions and new focus on Medicare Advantage, Mostashari delves into Aledade’s efforts to scale and deliver where average primary care practices can’t. Mostashari also reveals his approach to value based care incentive structure, and why building a valuable solution requires a long time horizon.
  1. Thinking Long Term is the Greatest Gift
  2. Diversifying the Cap Table
  3. The Balancing Act of Drug Discovery
  4. Bust the Liars Without Elevating the Liars
  5. Healthy Skepticism in Product Management